论文部分内容阅读
目的:探讨双岐三联活菌片与蒙脱石散联合治疗小儿腹泻的临床分析。方法:选取2012年6月到2014年6月进我院就诊的60例小儿腹泻患,根据患者入院时间进行随机分组:观察组和对照组,每组分配患者30例,观察组患者采用双岐三联活菌片联合蒙脱石散治疗,对照组患者单纯采用蒙脱石散治疗。在两组患者进行连续2个疗程的治疗后,对其治疗效果进行比对分析。结果:小儿腹泻治疗总有效率观察组以96.7%完胜80.0%的对照组,差异有统计学意义(P<0.05)。两组患儿均没有出现不良药物反应。结论:在进行小儿腹泻治疗时,可以采用双岐三联活菌片联合蒙脱石散治疗法,相比单纯的蒙脱石散治疗,该联合治疗法具有很大的优势,是一种性价比高、安全高效的治疗方式,值得推崇。
Objective: To investigate the clinical analysis of the treatment of infantile diarrhea by the combination of Bifid triplet viable tablets and montmorillonite powder. Methods: A total of 60 cases of infantile diarrhea admitted to our hospital from June 2012 to June 2014 were randomly divided into observation group and control group, 30 cases in each group and 2 cases in observation group Triptychomycosis tablets combined montmorillonite treatment, the control group of patients treated with montmorillonite alone. Two groups of patients in two consecutive courses of treatment, the treatment effect of comparison analysis. Results: The total effective rate of pediatric diarrhea treatment group with 96.7% victory over 80.0% of the control group, the difference was statistically significant (P <0.05). No adverse drug reactions occurred in both groups. Conclusion: In the treatment of infantile diarrhea, we can use Bifid triple viable tablets combined with montmorillonite powder therapy, compared to pure montmorillonite powder treatment, the combination therapy has great advantages, is a cost-effective , Safe and efficient treatment, worthy of praise.